ArticleOncoTargets and therapy2022

Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring

Yuri Yagami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.